4//SEC Filing
AQUINOX PHARMACEUTICALS, INC 4
Accession 0001209191-14-020599
$NGNECIK 0001404644operating
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 3:21 PM ET
Size
12.7 KB
Accession
0001209191-14-020599
Insider Transaction Report
Form 4
Main David
DirectorPresident and CEO
Transactions
- Disposition to Issuer
Common Exchangeable Shares
2014-03-12$11.00/sh−9,459$104,049→ 0 total→ Common Stock (9,459 underlying) - Disposition to Issuer
Common Special Voting Stock
2014-03-12$11.00/sh−9,459$104,049→ 71,530 total - Conversion
Common Stock
2014-03-12+71,530→ 71,530 total - Conversion
Common Exchangeable Shares
2014-03-12−71,530→ 0 total→ Common Stock (71,530 underlying) - Conversion
Common Special Voting Stock
2014-03-12−71,530→ 0 total
Footnotes (2)
- [F1]Each share of the issuer's Common, Series A-1, Series A-2, Series B-1, Series B-2 and Series C Special Voting Stock was redeemed upon the closing of the issuer's initial public offering for $0.0000192 per share.
- [F2]The Common Exchangeable Shares of Aquinox Pharmaceuticals Inc., a corporation under the Canadian Business Corporations Act ("AQXP Canada"), were exchanged for Common Stock of the issuer on a 1-to-1 basis upon the closing of the issuer's initial public offering, and have no expiration date.
Documents
Issuer
AQUINOX PHARMACEUTICALS, INC
CIK 0001404644
Entity typeoperating
Related Parties
1- filerCIK 0001404644
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 3:21 PM ET
- Size
- 12.7 KB